These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 5241417)
21. [Use of cytostatic preparations in certain severe dermatoses (psoriasis, pemphigus, hemodermia)]. Romanenko GF; Verbenko EV; Goncharova LI; Krepker IaB; Ezhov NIa Sov Med; 1974 Jul; 0(7):118-21. PubMed ID: 4137488 [No Abstract] [Full Text] [Related]
22. Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma. Kang MH; Harutyunyan N; Hall CP; Papa RA; Lock RB Br J Haematol; 2009 May; 145(3):389-93. PubMed ID: 19298590 [TBL] [Abstract][Full Text] [Related]
23. Controlled trial of methotrexate versus CH-1504 in the treatment of rheumatoid arthritis. Castaneda O; Nair MG J Rheumatol; 2006 May; 33(5):862-4. PubMed ID: 16652417 [TBL] [Abstract][Full Text] [Related]
24. [Unusual side effects of aminopterin]. Oswald FH Ned Tijdschr Geneeskd; 1967 May; 111(18):842-3. PubMed ID: 6042309 [No Abstract] [Full Text] [Related]
25. Folic acid supplementation and methotrexate therapy for psoriasis. Hughes R; Harries M; Chalmers RJ; Kirby B J Am Acad Dermatol; 2006 Aug; 55(2):366-7. PubMed ID: 16844540 [No Abstract] [Full Text] [Related]
26. Treatment of psoriasis by methotrexate. Kraus Z Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1976; 19(3-4):353-60. PubMed ID: 1072528 [No Abstract] [Full Text] [Related]
27. [Treatment of psoriasis by antimetabolites, especially methotrexate]. Krakowsky A; Brener S Harefuah; 1971 Apr; 80(8):440-2. PubMed ID: 5092685 [No Abstract] [Full Text] [Related]
28. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial. Salim A; Tan E; Ilchyshyn A; Berth-Jones J Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650 [TBL] [Abstract][Full Text] [Related]
29. Chromosomal abnormalities produced by folic acid antagonists. Ryan TJ; Boddington MM; Spriggs AI Br J Dermatol; 1965 Nov; 77(11):541-55. PubMed ID: 5853249 [No Abstract] [Full Text] [Related]
31. Methotrexate in psoriasis. Precipitation of gout. Martin JH; Gordon M; Wallace R Arch Dermatol; 1967 Oct; 96(4):431-3. PubMed ID: 6046389 [No Abstract] [Full Text] [Related]
32. [Clinical use of methotrexate in psoriasis]. Zhonghua Yi Xue Za Zhi; 1974; (10):646-7, 182. PubMed ID: 4434781 [No Abstract] [Full Text] [Related]
33. [Treatment of psoriasis with small doses of methotrexate]. Levkov AA; Kondinskaia VE; Etkind LI Vestn Dermatol Venerol; 1974 Nov; (11):75-7. PubMed ID: 4446735 [No Abstract] [Full Text] [Related]
34. [Analysis of serum proteins among psoriatics during methotrexate therapy]. Müller-Sutter T; Schwarz M; Schwarz K Dermatologica; 1968; 137(4):202-7. PubMed ID: 4176519 [No Abstract] [Full Text] [Related]
35. [Treatment of psoriasis using methotrexate]. Alvarez Lovell L Actas Dermosifiliogr; 1968; 59(9):521-31. PubMed ID: 5747296 [No Abstract] [Full Text] [Related]
36. Developmental delay in fetal aminopterin/methotrexate syndrome. Del Campo M; Kosaki K; Bennett FC; Jones KL Teratology; 1999 Jul; 60(1):10-2. PubMed ID: 10413333 [TBL] [Abstract][Full Text] [Related]
37. Methotrexate. I. Pharmacology and pharmacokinetics. Lippens RJ Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629 [TBL] [Abstract][Full Text] [Related]